FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years - Endpoints News

FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years – Endpoints News

July 6, 2026

FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years Endpoints News
FDA authorizes more devices so far in 2026, but it’s taking longer MedTech Dive
Regulatory Actions for June 2026 PharmTech.com
The June 2026 Shift: US FDA Approvals Redefining Global Standards drugscontrol.org
Despite chaos and churn, FDA decisions hold mostly steady in H1 2026 BioSpace